What's New

Conferences



Researchers Evaluate Current and Future Status of Clinical Trials at International FTD Conference

Alzforum’s coverage of the 2021 International Conference on Frontotemporal Dementia concludes with an update on FTD clinical trials.   According to the final article in the series, trials for carriers of GRN mutations are the farthest along in clinical trial developments. Julio Rojas of the University of California,…

More

Cohort Studies Join Together in Preparation for FTD Clinical Trials

In the sixth part of Alzforum’s coverage series of the 2021 International Conference on Frontotemporal Dementias, researchers provide an overview of how studies from around the world are uniting as clinical trials are in development.   One such initiative, the FTD Prevention Initiative (FPI), unites multicenter studies like GENFI and ALLFTD together. FPI is jointly led by…

More

Social-Emotional Tests in FTD Research Discussed at International FTD Conference

Alzforum’s coverage of the 2021 International Conference on Frontotemporal Dementias continues with a closer look into neuropsychological tests.   During the conference, researchers described the different tests that examine deficits in social and emotional cognition. According to the Alzforum article, Katherine Rankin of the University of California, San Francisco and colleagues have been working to validate four socioemotional…

More

Tests That May Track FTD Symptom Progression Discussed at International FTD Conference

Alzforum’s coverage of the 2021 International Conference on Frontotemporal Dementias continues with an overview of the standardized tests that are available for tracking symptoms of FTD.  In the fourth installment of Alzforum’s series, writer Jessica Shugart summarized FTD researchers’ attempts to develop standardized tests that objectively and comprehensively measure FTD symptoms.    One promising candidate is multidomain impairment rating (MIR), developed by Bradley Boeve, MD, of the Mayo Clinic (and AFTD’s Medical Advisory Council), along…

More

Researchers Discuss Neuroimaging Techniques at International FTD Conference

Alzforum’s conference coverage series of the International Conference on Frontotemporal Dementias has continued. The third article in the series looked into the neuroimaging techniques that investigate patterns of atrophy, white-matter erosion, and a breakdown of neural circuitry in sporadic and familial forms of FTD.  During the conference, researchers described…

More

Researchers Provide Updates on Fluid Biomarkers at International FTD Conference

The second installment of Alzforum’s conference coverage series of the International Conference on Frontotemporal Dementias highlighted researchers’ insight on fluid biomarkers in FTD neuropathology.   According to the Alzforum article, FTD researchers shared their findings on neurofilament light (NfL), which was established as the best-validated fluid biomarker for FTD, with NfL levels rising in both cerebrospinal fluid (CSF) and…

More

International FTD Conference Emphasizes Importance of Collaborative FTD Research

Throughout the week, Alzforum is publishing a summation of this year’s International Conference on Frontotemporal Dementias in a seven-part series of articles emphasizing the importance of collaboration between FTD researchers around the world.  The International Society for Frontotemporal Dementias virtually convened the 12th International Conference on FTD on March 3-5.   Alzforum’s first installment of its conference…

More